Current position:Home >Product >
		
		
	
(2S)-1-morpholin-4-ium-4-yl-3-[4-(2-phenylpropan-2-yl)phenoxy]propan-2-ol
(2S)-1-morpholin-4-ium-4-yl-3-[4-(2-phenylpropan-2-yl)phenoxy]propan-2-ol
		
  | 
      
	   
		
		   | 
      
Canonical SMILES:
CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)OCC(C[NH+]3CCOCC3)O
Isomeric SMILES
CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)OC[C@H](C[NH+]3CCOCC3)O
InChI
InChI=1S/C22H29NO3/c1-22(2,18-6-4-3-5-7-18)19-8-10-21(11-9-19)26-17-20(24)16-23-12-14-25-15-13-23/h3-11,20,24H,12-17H2,1-2H3/p+1/t20-/m0/s1
      
		
	   Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
 - 2,5-bis(chloranyl)benzene-1,4-diol
 - 2,5-bis(chloranyl)phenol
 - 2-oxidanylidenehexanedioic acid
 - 2-oxidanylidene-3-sulfanyl-propanoic acid
 - 3-oxidanylbenzaldehyde
 - 3-azanylpropanal
 - 2-azanyl-3-oxidanyl-benzoic acid
 - 3-(3-hydroxyphenyl)propanoic acid
 - 3-oxidanylidenehexanedioic acid
 - 6-methyl-3-[(S)-[1-(2-methylbutan-2-yl)-1,2,3,4-tetrazol-5-yl]-morpholin-4-ium-4-yl-methyl]-1H-quinolin-2-one
 - 3-[(R)-[1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrazol-5-yl]-morpholin-4-ium-4-yl-methyl]-6-methyl-1H-quinolin-2-one
 - 3-[(R)-(1-cyclopentyl-1,2,3,4-tetrazol-5-yl)-(4-oxidanylpiperidin-1-ium-1-yl)methyl]-6-ethyl-1H-quinolin-2-one
 - 6-ethyl-3-[(R)-[1-(2-methylbutan-2-yl)-1,2,3,4-tetrazol-5-yl]-pyrrolidin-1-ium-1-yl-methyl]-1H-quinolin-2-one
 - 6-ethyl-3-[(R)-[1-(2-methylbutan-2-yl)-1,2,3,4-tetrazol-5-yl]-piperidin-1-ium-1-yl-methyl]-1H-quinolin-2-one
 - 6-ethyl-3-[(R)-[1-(2-methylbutan-2-yl)-1,2,3,4-tetrazol-5-yl]-(4-methylpiperidin-1-ium-1-yl)methyl]-1H-quinolin-2-one
 - 3-[(R)-azepan-1-ium-1-yl-[1-(2-methylbutan-2-yl)-1,2,3,4-tetrazol-5-yl]methyl]-6-ethyl-1H-quinolin-2-one
 - 6-ethyl-3-[(R)-[1-(2-methylbutan-2-yl)-1,2,3,4-tetrazol-5-yl]-morpholin-4-ium-4-yl-methyl]-1H-quinolin-2-one
 - 6-ethyl-3-[(R)-[1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrazol-5-yl]-morpholin-4-ium-4-yl-methyl]-1H-quinolin-2-one
 - 4-[[(6R)-3-aminocarbonyl-6-tert-butyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]amino]-4-oxidanylidene-butanoate
 

               
       